» Articles » PMID: 39872372

Biochemical Mechanisms and Molecular Interactions of Vitamins in Cancer Therapy

Abstract

Recently, the potential role of vitamins in cancer therapy has attracted considerable research attention. However, the reported findings are inconsistent, with limited information on the biochemical and molecular interactions of different vitamins in various cancer cells. Importantly, the presence of vitamin receptors in tumor cells suggests that vitamins play a significant role in the molecular and biochemical interactions in cancers. Additionally, studies on the efficacy of vitamin supplementation and dosage levels on tumor progression and mortality risk have yielded inconsistent results. Notably, molecular and biochemical investigations have reported the function of vitamins in the proliferation, growth, and invasiveness of tumor cells, as well as in cell cycle arrest and inflammatory signaling. Additionally, different vitamins may regulate the cancer microenvironment by activating various molecular pathways. Vitamins significantly affect immunological function, antioxidant defense, inflammation, and epigenetic control, and can improve treatment outcomes by affecting cell behavior and combating stress and DNA damage. However, further research is necessary to confirm the efficacy of vitamins, establish ideal dosages, and develop effective cancer prevention and treatment plans. Individualized supplementation plans guided by medical knowledge are crucial to achieving optimal results in clinical and preclinical settings. In this review, we critically evaluated the effects of different vitamins on the risk and development of cancer. Additionally, we examined the potential of vitamin supplements to enhance the efficacy of drug therapy and counteract resistance mechanisms that often arise during cancer treatment.

Citing Articles

Advances in pyrazolo[1,5-]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment.

Iorkula T, Jude-Kelly Osayawe O, Odogwu D, Ganiyu L, Faderin E, Awoyemi R RSC Adv. 2025; 15(5):3756-3828.

PMID: 39911541 PMC: 11795850. DOI: 10.1039/d4ra07556k.

References
1.
Araghi S, Kiefte-de Jong J, van Dijk S, Swart K, van Laarhoven H, van Schoor N . Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer Epidemiol Biomarkers Prev. 2018; 28(2):275-282. DOI: 10.1158/1055-9965.EPI-17-1198. View

2.
Liu C, Shi X, Wang L, Wu Y, Jin F, Bai C . SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. Tumour Biol. 2014; 35(6):6073-82. DOI: 10.1007/s13277-014-1804-5. View

3.
Bober P, Alexovic M, Talian I, Tomkova Z, Viscorova Z, Benckova M . Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line. J Cancer Res Clin Oncol. 2016; 143(1):35-42. DOI: 10.1007/s00432-016-2259-4. View

4.
Tabatabayi Z, Homayouni-Tabrizi M, Neamati A, Beyramabadi S . Mn(II) complex of a vitamin B6 Schiff base as an exclusive apoptosis inducer in human MCF7 and HepG2 cancer cells: Synthesis, characterization, and biological studies. J Cell Biochem. 2019; 121(3):2677-2689. DOI: 10.1002/jcb.29488. View

5.
Lopez-Caleya J, Ortega-Valin L, Fernandez-Villa T, Delgado-Rodriguez M, Martin-Sanchez V, Molina A . The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer Causes Control. 2021; 33(2):167-182. DOI: 10.1007/s10552-021-01512-3. View